News
AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to...
AMRI announced its ongoing commitment to do its part in support of public health needs amidst the COVID-19 pandemic. The company continues to focus on...
News
Applied BioMath, LLC Announces Collaboration with Zymeworks
Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced the continuation of their...
News
Vaxart Announces Additional Positive Pre-Clinical Data for its Oral...
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has obtained positive...
News
Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing...
Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced the enrollment of...
News
Massachusetts Hospital to Assess Mallinckrodt’s Nitric Oxide Treatment for...
Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients infected...
Drug Research
Trio pharmaceuticals and ajinomoto bio pharma services enter into...
Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto Bio-Pharma Services, have entered a development collaboration to evaluate AJICAP,...
News
Gilead’s drug remdesivir gets US FDA’s emergency use authorisation...
Gilead was granted EUA by U.S. FDA for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to treat...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.